Form 4: Lexaria Bioscience Corp. Director Albert Reese Jr. Acquires Stock Options
SEC Form 4 Filing
Director Albert Reese Jr. reports acquisition of 12,000 stock options in Lexaria Bioscience Corp.
Summary
- On July 30, 2024, Albert Reese Jr., a director of Lexaria Bioscience Corp., filed a Form 4.
- The form reports the acquisition of 12,000 stock options with an exercise price of $3.39 on July 26, 2024.
- These options are exercisable from July 26, 2024, and expire on July 26, 2029.
- Reese also directly owns 10,917 common shares.
- Following the reported transaction, Reese beneficially owns 32,000 stock options.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock option acquisition. The director's acquisition could be interpreted as a slightly positive signal.
Positives
- A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions and provides insight into the compensation structure and ownership of Lexaria Bioscience Corp.
Stakeholder Impact
- The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 02/01/2021 | Date exercisable for 3,400 stock options at $3 |
| 02/01/2026 | Expiration date for 3,400 stock options at $3 |
| 03/08/2022 | Date exercisable for 3,400 stock options at $3.39 |
| 03/08/2027 | Expiration date for 3,400 stock options at $3.39 |
| 05/09/2023 | Shareholder approval received to reprice stock options from $4.80 |
| 07/25/2023 | Date exercisable for 5,000 stock options at $0.87 |
| 07/25/2028 | Expiration date for 5,000 stock options at $0.87 |
| 04/26/2024 | Date exercisable for 5,000 stock options at $2.36 |
| 04/26/2029 | Expiration date for 5,000 stock options at $2.36 |
| 07/26/2024 | Date of transaction and date exercisable for 12,000 stock options at $3.39 |
| 07/26/2029 | Expiration date for 12,000 stock options at $3.39 |
| 07/30/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.